Evidence map›Paper›PMID 40503310›Full record

ArticleRSC advances2025

Discovery of potential small molecule inhibitors against β-hCG: an

Shreya Sara Ittycheria, Krishnankutty Chandrika Sivakumar, Dipyaman Patra, Bhavana Ramachandran, R L Neetha, Arathy V Warrier, M A Aiswariya, S Kaviya, Pankaj Suman, Nagarjun Narayanaswamy and 1 more

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shreya Sara IttycheriaCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Krishnankutty Chandrika SivakumarCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Dipyaman PatraCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Bhavana RamachandranCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
R L NeethaCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Arathy V WarrierCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
M A AiswariyaCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
S KaviyaCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Pankaj SumanNational Institute of Animal Biotechnology Gachibowli Hyderabad Telangana 500032 India.
Nagarjun NarayanaswamyCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.
Priya SrinivasCancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology Thycaud Thiruvananthapuram 695014 Kerala India priyasrinivas@rgcb.res.in +91-471-2529495.ORCID https://orcid.org/0000-0003-3872-7128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous

Identifiers

PMID40503310
PMCPMC12150210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.